CV Event Prediction, Risk Assessment in Type 2 Diabetes
The risk assessment method used in the SAVOR-53 TIMI trial provided a “practical, well-calibrated risk prediction tool.”
Perioperative major adverse cardiovascular and cerebrovascular events may be more common in patients with diabetes.
Investigators sought to determine an association between diabetes and HbA1C with postoperative outcomes.
Overall, once-weekly semaglutide 1.0 mg as an add-on to basal insulin is the most efficacious GLP-1 receptor agonist in terms of reductions in HbA1c and body weight from baseline after ...